228 related articles for article (PubMed ID: 35848051)
1. Cell Surface Calcium-Sensing Receptor Heterodimers: Mutant Gene Dosage Affects Ca
Goolam MA; Brown AP; Edwards KT; Gregory KJ; Leach K; Conigrave AD
J Bone Miner Res; 2022 Sep; 37(9):1787-1807. PubMed ID: 35848051
[TBL] [Abstract][Full Text] [Related]
2. Reduced affinity of calcium sensing-receptor heterodimers and reduced mutant homodimer trafficking combine to impair function in a model of familial hypocalciuric hypercalcemia type 1.
Wang X; Lundblad J; Smith SM
PLoS One; 2022; 17(7):e0266993. PubMed ID: 35857775
[TBL] [Abstract][Full Text] [Related]
3. Calcium signaling regulates trafficking of familial hypocalciuric hypercalcemia (FHH) mutants of the calcium sensing receptor.
Grant MP; Stepanchick A; Breitwieser GE
Mol Endocrinol; 2012 Dec; 26(12):2081-91. PubMed ID: 23077345
[TBL] [Abstract][Full Text] [Related]
4. Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites.
Hannan FM; Nesbit MA; Zhang C; Cranston T; Curley AJ; Harding B; Fratter C; Rust N; Christie PT; Turner JJ; Lemos MC; Bowl MR; Bouillon R; Brain C; Bridges N; Burren C; Connell JM; Jung H; Marks E; McCredie D; Mughal Z; Rodda C; Tollefsen S; Brown EM; Yang JJ; Thakker RV
Hum Mol Genet; 2012 Jun; 21(12):2768-78. PubMed ID: 22422767
[TBL] [Abstract][Full Text] [Related]
5. A G-protein Subunit-α11 Loss-of-Function Mutation, Thr54Met, Causes Familial Hypocalciuric Hypercalcemia Type 2 (FHH2).
Gorvin CM; Cranston T; Hannan FM; Rust N; Qureshi A; Nesbit MA; Thakker RV
J Bone Miner Res; 2016 Jun; 31(6):1200-6. PubMed ID: 26729423
[TBL] [Abstract][Full Text] [Related]
6. Markedly reduced activity of mutant calcium-sensing receptor with an inserted Alu element from a kindred with familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.
Bai M; Janicic N; Trivedi S; Quinn SJ; Cole DE; Brown EM; Hendy GN
J Clin Invest; 1997 Apr; 99(8):1917-25. PubMed ID: 9109436
[TBL] [Abstract][Full Text] [Related]
7. The pathophysiology of primary hyperparathyroidism.
Brown EM
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N24-9. PubMed ID: 12412774
[TBL] [Abstract][Full Text] [Related]
8. Naturally-occurring mutation in the calcium-sensing receptor reveals the significance of extracellular domain loop III region for class C G-protein-coupled receptor function.
Dong Q; Cheng Z; Chang W; Blackman BE; Conte FA; Hu J; Shoback D; Miller WL
J Clin Endocrinol Metab; 2010 Oct; 95(10):E245-52. PubMed ID: 20631026
[TBL] [Abstract][Full Text] [Related]
9. New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT).
Rodrigues LS; Cáu AC; Bussmann LZ; Bastida G; Brunetto OH; Corrêa PH; Martin RM
Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):67-71. PubMed ID: 21468522
[TBL] [Abstract][Full Text] [Related]
10. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
[TBL] [Abstract][Full Text] [Related]
11. Impaired cotranslational processing of the calcium-sensing receptor due to signal peptide missense mutations in familial hypocalciuric hypercalcemia.
Pidasheva S; Canaff L; Simonds WF; Marx SJ; Hendy GN
Hum Mol Genet; 2005 Jun; 14(12):1679-90. PubMed ID: 15879434
[TBL] [Abstract][Full Text] [Related]
12. Subtotal Parathyroidectomy Successfully Controls Calcium Levels of Patients with Neonatal Severe Hyperparathyroidism Carrying a Novel CASR Mutation.
Wejaphikul K; Dejkhamron P; Khorana J; Watcharachan K; Intachai W; Olsen B; Tongsima S; Ketudat Cairns JR; Ngamphiw C; Kantaputra P
Horm Res Paediatr; 2023; 96(4):432-438. PubMed ID: 36626889
[TBL] [Abstract][Full Text] [Related]
13. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
[TBL] [Abstract][Full Text] [Related]
14. An adult patient with severe hypercalcaemia and hypocalciuria due to a novel homozygous inactivating mutation of calcium-sensing receptor.
Chikatsu N; Fukumoto S; Suzawa M; Tanaka Y; Takeuchi Y; Takeda S; Tamura Y; Matsumoto T; Fujita T
Clin Endocrinol (Oxf); 1999 Apr; 50(4):537-43. PubMed ID: 10468915
[TBL] [Abstract][Full Text] [Related]
15. Heterozygous inactivating CaSR mutations causing neonatal hyperparathyroidism: function, inheritance and phenotype.
Glaudo M; Letz S; Quinkler M; Bogner U; Elbelt U; Strasburger CJ; Schnabel D; Lankes E; Scheel S; Feldkamp J; Haag C; Schulze E; Frank-Raue K; Raue F; Mayr B; Schöfl C
Eur J Endocrinol; 2016 Nov; 175(5):421-31. PubMed ID: 27666534
[TBL] [Abstract][Full Text] [Related]
16. Identification and functional analysis of a novel CaSR mutation in a family with familial hypocalciuric hypercalcemia.
Kim ES; Kim SY; Lee JY; Han JH; Sohn TS; Son HS; Moon SD
J Bone Miner Metab; 2016 Nov; 34(6):662-667. PubMed ID: 26386835
[TBL] [Abstract][Full Text] [Related]
17. Identification and functional analysis of novel calcium-sensing receptor gene mutation in familial hypocalciuric hypercalcemia.
Nanjo K; Nagai S; Shimizu C; Tajima T; Kondo T; Miyoshi H; Yoshioka N; Koike T
Endocr J; 2010; 57(9):787-92. PubMed ID: 20697181
[TBL] [Abstract][Full Text] [Related]
18. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor].
Watanabe S; Fukumoto S
Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921
[TBL] [Abstract][Full Text] [Related]
19. Personalised medicines for familial hypercalcemia and hyperparathyroidism.
Josephs TM; Zhang F; Dinh LV; Keller AN; Conigrave AD; Capuano B; Gregory KJ; Leach K
J Mol Endocrinol; 2022 May; 69(1):243-257. PubMed ID: 35318962
[TBL] [Abstract][Full Text] [Related]
20. A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia.
Hannan FM; Nesbit MA; Christie PT; Lissens W; Van der Schueren B; Bex M; Bouillon R; Thakker RV
Clin Endocrinol (Oxf); 2010 Dec; 73(6):715-22. PubMed ID: 20846291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
